Axsome Therapeutics, Inc. ($AXSM)
Coleman Mark โ Director
Shares
5,193
Price
$8.02
Total Value
$41,647.86
Nearby Earnings
Feb 17, 2026
EPS:Est: -0.71
Revenue:Est: $191.33M
Feb 23, 2026
EPS:Est: -0.70
Revenue:Est: $192.82M
Transaction Details
| Insider | Coleman Mark |
|---|---|
| Title | Director |
| Transaction Date | Feb 10, 2026 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 11, 2026 |
| Document Date | Feb 10, 2026 |
| Shares Purchased | 5,193 |
| Price per Share | $8.02 |
| Total Value | $41,647.86 |
| Shares Owned After | 53,405 |
| Derivative | No |
| Accession Number | 0001193125-26-045110 |
| Document | View SEC Filing |